Disc Medicine Insider Trades
NASDAQ: IRONHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 55 · $21.75M
- Shares bought / sold
- 0 / 297.34K
- Net activity
- Net selling $21.7 million
Disc Medicine insider activity
Over the last 12 months, Disc Medicine insiders reported 82 transactions on SEC Form 4: 0 open-market purchases and 55 sales. Insiders bought $0 and sold $21.7 million worth of stock, for net insider selling of $21.7 million. The largest seller was Quisel John D, with $8.3 million in reported sales.
The most recent filing shows Quisel John D (Chief Executive Officer) reporting a transaction in 36,000 shares at $1.01 on Sep 15, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put IRON's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
IRON insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 15, 2026 | Quisel John DChief Executive Officer | Option exercise | 36,000 | $36.36K | Form 4 |
| Sep 11, 2026 | Bitterman KevinDirector | Sale | 27,136 | $1.90M | Form 4 |
| Sep 11, 2026 | Bitterman KevinDirector | Option exercise | 10,000 | $508.60K | Form 4 |
| Sep 11, 2026 | Bitterman KevinDirector | Option exercise | 10,000 | $388.50K | Form 4 |
| Sep 11, 2026 | Bitterman KevinDirector | Option exercise | 7,136 | $326.04K | Form 4 |
| Sep 4, 2026 | Bitterman KevinDirector | Sale | 18 | $1.44K | Form 4 |
| Sep 4, 2026 | Bitterman KevinDirector | Sale | 759 | $60.69K | Form 4 |
| Sep 4, 2026 | Bitterman KevinDirector | Sale | 912 | $72.92K | Form 4 |
| Sep 3, 2026 | Bitterman KevinDirector | Sale | 54 | $4.32K | Form 4 |
| Sep 3, 2026 | Bitterman KevinDirector | Sale | 2,339 | $187.07K | Form 4 |
| Sep 3, 2026 | Bitterman KevinDirector | Sale | 2,810 | $224.74K | Form 4 |
| Sep 2, 2026 | Bitterman KevinDirector | Sale | 2 | $161.96 | Form 4 |
| Sep 2, 2026 | Bitterman KevinDirector | Sale | 9 | $728.82 | Form 4 |
| Sep 2, 2026 | Bitterman KevinDirector | Sale | 10 | $809.80 | Form 4 |
| Sep 2, 2026 | Bitterman KevinDirector | Sale | 511 | $40.97K | Form 4 |
| Sep 2, 2026 | Bitterman KevinDirector | Sale | 22,090 | $1.77M | Form 4 |
| Sep 2, 2026 | Bitterman KevinDirector | Sale | 26,542 | $2.13M | Form 4 |
| Sep 1, 2026 | Bitterman KevinDirector | Sale | 1 | $79.95 | Form 4 |
| Sep 1, 2026 | Bitterman KevinDirector | Sale | 58 | $4.64K | Form 4 |
| Sep 1, 2026 | Bitterman KevinDirector | Sale | 70 | $5.60K | Form 4 |
| Aug 25, 2026 | Yu Jonathan Yen-WenChief Operating Officer | Sale | 8,796 | $731.09K | Form 4 |
| Aug 25, 2026 | Yu Jonathan Yen-WenChief Operating Officer | Option exercise | 8,796 | $118.75K | Form 4 |
| Aug 24, 2026 | Yu Jonathan Yen-WenChief Operating Officer | Sale | 300 | $24.76K | Form 4 |
| Aug 24, 2026 | Yu Jonathan Yen-WenChief Operating Officer | Option exercise | 300 | $4.05K | Form 4 |
| Aug 17, 2026 | Quisel John DChief Executive Officer | Sale | 11,888 | $949.16K | Form 4 |
| Aug 17, 2026 | Quisel John DChief Executive Officer | Sale | 12,712 | $1.01M | Form 4 |
| Aug 17, 2026 | Quisel John DChief Executive Officer | Sale | 8,400 | $656.09K | Form 4 |
| Aug 17, 2026 | Quisel John DChief Executive Officer | Option exercise | 33,000 | $445.50K | Form 4 |
| Aug 12, 2026 | Yu Jonathan Yen-WenChief Operating Officer | Sale | 804 | $66.44K | Form 4 |
| Aug 12, 2026 | Yu Jonathan Yen-WenChief Operating Officer | Option exercise | 804 | $10.85K | Form 4 |
| Aug 6, 2026 | Khara RahulChief Legal Officer | Sale | 5,000 | $400.00K | Form 4 |
| Aug 6, 2026 | Khara RahulChief Legal Officer | Option exercise | 5,000 | $73.45K | Form 4 |
| Jul 13, 2026 | Quisel John DChief Executive Officer | Sale | 6,400 | $486.73K | Form 4 |
| Jul 13, 2026 | Quisel John DChief Executive Officer | Sale | 16,896 | $1.27M | Form 4 |
| Jul 13, 2026 | Quisel John DChief Executive Officer | Sale | 9,704 | $720.74K | Form 4 |
| Jul 13, 2026 | Quisel John DChief Executive Officer | Option exercise | 7,416 | $100.12K | Form 4 |
| Jul 13, 2026 | Quisel John DChief Executive Officer | Option exercise | 25,584 | $252.26K | Form 4 |
| Jul 7, 2026 | Yu Jonathan Yen-WenChief Operating Officer | Sale | 100 | $8.25K | Form 4 |
| Jul 7, 2026 | Yu Jonathan Yen-WenChief Operating Officer | Option exercise | 100 | $1.35K | Form 4 |
| Jun 29, 2026 | Khara RahulChief Legal Officer | Sale | 1,649 | $123.67K | Form 4 |
| Jun 29, 2026 | Khara RahulChief Legal Officer | Option exercise | 1,649 | $24.22K | Form 4 |
| Jun 26, 2026 | Yu Jonathan Yen-WenChief Operating Officer | Sale | 300 | $21.75K | Form 4 |
| Jun 26, 2026 | Yu Jonathan Yen-WenChief Operating Officer | Option exercise | 300 | $4.05K | Form 4 |
| Jun 26, 2026 | Khara RahulChief Legal Officer | Sale | 851 | $63.83K | Form 4 |
| Jun 26, 2026 | Khara RahulChief Legal Officer | Option exercise | 851 | $12.50K | Form 4 |
| Jun 22, 2026 | Yu Jonathan Yen-WenChief Operating Officer | Sale | 9,700 | $704.80K | Form 4 |
| Jun 22, 2026 | Yu Jonathan Yen-WenChief Operating Officer | Option exercise | 9,700 | $130.95K | Form 4 |
| Jun 18, 2026 | Quisel John DChief Executive Officer | Sale | 1,551 | $111.07K | Form 4 |
| Jun 18, 2026 | Quisel John DChief Executive Officer | Sale | 9,522 | $673.21K | Form 4 |
| Jun 18, 2026 | Quisel John DChief Executive Officer | Sale | 22,927 | $1.60M | Form 4 |
| Jun 18, 2026 | Quisel John DChief Executive Officer | Option exercise | 34,000 | $335.24K | Form 4 |
| Jun 18, 2026 | Khara RahulChief Legal Officer | Sale | 500 | $35.81K | Form 4 |
| Jun 18, 2026 | Khara RahulChief Legal Officer | Sale | 1,600 | $113.16K | Form 4 |
| Jun 18, 2026 | Khara RahulChief Legal Officer | Sale | 5,400 | $377.69K | Form 4 |
| Jun 18, 2026 | Khara RahulChief Legal Officer | Option exercise | 7,500 | $110.17K | Form 4 |
| Jun 16, 2026 | Yu Jonathan Yen-WenChief Operating Officer | Sale | 6,961 | $486.70K | Form 4 |
| Jun 16, 2026 | Yu Jonathan Yen-WenChief Operating Officer | Sale | 11,651 | $801.10K | Form 4 |
| Jun 16, 2026 | Yu Jonathan Yen-WenChief Operating Officer | Option exercise | 13,351 | $131.64K | Form 4 |
| Jun 16, 2026 | Yu Jonathan Yen-WenChief Operating Officer | Option exercise | 5,261 | $51.87K | Form 4 |
| Apr 14, 2026 | Franchi Jean M.Chief Financial Officer | Sale | 6,257 | $433.23K | Form 4 |
| Apr 13, 2026 | Franchi Jean M.Chief Financial Officer | Sale | 400 | $27.60K | Form 4 |
| Apr 13, 2026 | Savage William JacobChief Medical Officer | Sale | 2,200 | $146.98K | Form 4 |
| Apr 13, 2026 | Savage William JacobChief Medical Officer | Sale | 3,531 | $233.47K | Form 4 |
| Mar 2, 2026 | Savage William JacobChief Medical Officer | Sale | 2,986 | $198.30K | Form 4 |
| Mar 2, 2026 | Savage William JacobChief Medical Officer | Sale | 4,392 | $287.77K | Form 4 |
| Feb 25, 2026 | Franchi Jean M.Chief Financial Officer | Sale | 353 | $24.38K | Form 4 |
| Feb 18, 2026 | Franchi Jean M.Chief Financial Officer | Sale | 3,684 | $242.73K | Form 4 |
| Feb 18, 2026 | Franchi Jean M.Chief Financial Officer | Sale | 3,397 | $220.84K | Form 4 |
| Feb 17, 2026 | Quisel John DChief Executive Officer | Sale | 13,264 | $833.78K | Form 4 |
| Feb 17, 2026 | Yu Jonathan Yen-WenChief Operating Officer | Sale | 3,231 | $203.10K | Form 4 |
| Feb 17, 2026 | Stephenson PamelaChief Commercial Officer | Sale | 5,531 | $347.68K | Form 4 |
| Feb 17, 2026 | Savage William JacobChief Medical Officer | Sale | 3,256 | $204.67K | Form 4 |
| Feb 17, 2026 | Khara RahulChief Legal Officer | Sale | 2,853 | $179.34K | Form 4 |
| Feb 17, 2026 | Franchi Jean M.Chief Financial Officer | Sale | 4,075 | $256.15K | Form 4 |
| Feb 10, 2026 | Franchi Jean M.Chief Financial Officer | Award | 19,000 | — | Form 4 |
| Feb 10, 2026 | Yu Jonathan Yen-WenChief Operating Officer | Award | 17,000 | — | Form 4 |
| Feb 10, 2026 | Savage William JacobChief Medical Officer | Award | 17,000 | — | Form 4 |
| Feb 10, 2026 | Quisel John DChief Executive Officer | Award | 55,200 | — | Form 4 |
| Feb 10, 2026 | Stephenson PamelaChief Commercial Officer | Award | 17,000 | — | Form 4 |
| Feb 10, 2026 | Khara RahulChief Legal Officer | Award | 17,000 | — | Form 4 |
| Jan 20, 2026 | Khara RahulChief Legal Officer | Sale | 1,000 | $69.74K | Form 4 |
| Jan 20, 2026 | Khara RahulChief Legal Officer | Option exercise | 1,000 | $13.50K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4